Aliah M. Alhayyan

A PRISMA-guided systematic review of pharmacogenetic anticancer clinical trials registered on clinicaltrials.gov

Pharmacogenetic approaches are increasingly being incorporated into anticancer clinical trials and may contribute to the advancement of precision oncology, however, broader global representation, larger late-phase trials, and more standardized biomarker integration remain necessary to support wider clinical implementat...